Table 1.
Demographic profile, affected joints, previous rheumatic diseases, and previous treatment in patients with CHIKA
| Number of patients | 133 |
| Age (years) | |
| Mean ± SD | 58.6 ± 13.7 |
| Median (range) | 58.0 (26–82) |
| Time between onset of symptoms and first visit (days) | |
| Mean ± SD | 42.16 ± 20.45 |
| Female, n (%) | 119 (89.5) |
| Affected joints, n (%) | |
| Wrists | 122 (91.7) |
| Proximal interphalangeal | 113 (86.9) |
| Ankles | 111 (83.4) |
| Shoulders | 100 (75.1) |
| Knees | 97 (72.9) |
| Metacarpophalangeal | 72 (54.1) |
| Elbows | 54 (40.6) |
| Prior treatment of CHIKA, n (%) | |
| Corticosteroids | 89 (66.9) |
| Acetaminophen or dipyrone | 78 (58.6) |
| Pregabalin, codeine, or tramadol | 19 (14.2) |
| NSAIDs | 6 (4.5) |
| DMARDs (MTX) | 1 (0.7) |
| Previous reported rheumatic diseases, n (%) | |
| Osteoarthritis | 27 (20.3) |
| Osteoporosis | 16 (12) |
| Tendinitis/bursitis | 6 (4.5) |
| Fibromyalgia | 4 (3) |
| Rheumatoid arthritis | 2 (1.5) |
| Rheumatic fever | 1 (0.75) |
CHIKA = chikungunya arthritis; DMARD = disease-modifying antirheumatic drug; MTX = methotrexate; NSAID = nonsteroidal anti-inflammatory drug.